Furthermore, items containing dynamic elements that rely on user interaction (such as assessing the behavior of a physical system) can only be administered when using third-party technological solutions, e.g., based on Adobe Flash (Triantafillou, Georgiadou, & Economides, 2008) or Java Applets (Conejo et al., 2004), which do not integrate with the testing system.
Because beta-lactams are rather safe drugs, a practical approach commonly used is to start with a loading dose equal to the first dose normally administered when using II, followed immediately by CI using the same total daily dose as in II (note that in doing so, one creates essentially a single serum peak equivalent to what is obtained repeatedly with II).
Similar overall adverse event profiles were found for darifenacin, fesoterodine, transdermal oxybutynin, propiverine, solifenacin, tolterodine, and trospium chloride but not for oxybutynin orally administered when currently used starting dosages were compared.
We found similar overall adverse event profiles for darifenacin, fesoterodine, transdermal oxybutynin, propiverine, solifenacin, tolterodine, and trospium chloride but not for oxybutynin orally administered when currently used starting dosages were compared (Figure 1).
Overall adverse event profiles were similar for all antimuscarinics except for oxybutynin orally administered when comparing currently used starting dosages.
This approach minimizes toxicities and ensures that chemotherapy is administered when its effect can be assessed using measurable disease.
Furthermore, in a review article regarding cardiogenic shock, Reynolds and Hochman 27 have suggested that the lowest possible doses should be administered when vasopressor and inotropic agents are used, due to a possible relationship between high doses of vasoactive agents and worse survival outcomes.
These findings provide some evidence to support the intra-rater reliability of the instrument when administered among adolescent females, particularly when using outcome scores from the five dimensions and total wellness.
Second, Chandler et al. (19) have robustly demonstrated the importance of longer-term observation when using systemically administered AAV vectors during the neonatal period to monitor for hepatic genotoxicity.
36.8% of the i.v. treated patients did not see any positive aspect by p.o. chemotherapy with regard to better coping with breast cancer; only 14.1% strongly believed in a better coping when using orally administered drugs (Table 2 - question 8).
This quantitative study shows that one should be prepared to administer higher doses of insulin when using dexamethasone in cardiac surgery patients.
